GATTI, MILO
GATTI, MILO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Ricercatori a tempo determinato
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol
2021 Gatti, Milo; Bartoletti, Michele; Cojutti, Pier Giorgio; Gaibani, Paolo; Conti, Matteo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia
2023 Gatti, Milo; Pascale, Renato; Cojutti, Pier Giorgio; Rinaldi, Matteo; Ambretti, Simone; Conti, Matteo; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico
A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings
2021 Gatti M.; Cojutti P.G.; Campoli C.; Caramelli F.; Corvaglia L.T.; Lanari M.; Pession A.; Ramirez S.; Viale P.; Pea F.
A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis
2022 Gatti, M; Tedeschi, S; Trapani, F; Ramirez, S; Mancini, R; Giannella, M; Viale, P; Pea, F
Adaptive trials of new antimicrobials for infections with carbapenem-resistant, Gram-negative bacteria
2020 Gatti M.; Giannella M.; Scudeller L.; Viale P.
Advances in the therapy of bacterial bloodstream infections
2020 Giannella M.; Bartoletti M.; Gatti M.; Viale P.
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system
2021 Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of bsis, cutis, and ciais caused by enterobacterales in critically ill adult patients
2021 Gatti M.; Viaggi B.; Rossolini G.M.; Pea F.; Viale P.
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients
2021 Gatti M.; Viaggi B.; Rossolini G.M.; Pea F.; Viale P.
An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by Pseudomonas aeruginosa and Acinetobacter baumannii in Critically Ill Adult Patients
2022 Gatti M.; Viaggi B.; Rossolini G.M.; Pea F.; Viale P.
Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics
2021 Gatti M.; Pea F.
Assessing the association between fluoroquinolones and emerging adverse drug reactions raised by regulatory agencies: An umbrella review
2020 Gatti M.; Bianchin M.; Raschi E.; De Ponti F.
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections
2021 Gatti M.; Cojutti P.G.; Pascale R.; Tonetti T.; Laici C.; Dell'olio A.; Siniscalchi A.; Giannella M.; Viale P.; Pea F.
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems
2021 Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E.
Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysis
2021 Filippini D.M.; Gatti M.; Di Martino V.; Cavalieri S.; Fusaroli M.; Ardizzoni A.; Raschi E.; Licitra L.
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study
2021 Rinaldi M.; Bartoletti M.; Ferrarese A.; Franceschini E.; Campoli C.; Coladonato S.; Pascale R.; Tedeschi S.; Gatti M.; Cricca M.; Ambretti S.; Siniscalchi A.; Morelli M.C.; Cescon M.; Cillo U.; Di Benedetto F.; Burra P.; Mussini C.; Cristini F.; Lewis R.; Viale P.; Giannella M.
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study
2021 Rinaldi M.; Bartoletti M.; Ferrarese A.; Franceschini E.; Campoli C.; Coladonato S.; Pascale R.; Tedeschi S.; Gatti M.; Cricca M.; Ambretti S.; Siniscalchi A.; Morelli M.C.; Cescon M.; Cillo U.; Di Benedetto F.; Burra P.; Mussini C.; Cristini F.; Lewis R.; Viale P.; Giannella M.
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis
2021 Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M.
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis
2021 Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M.
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing
2021 Gatti, Milo; Giannella, Maddalena; Raschi, Emanuel; Viale, Pierluigi; De Ponti, Fabrizio